For example, whereas anti-cancer properties have been traditionally attributed to putative S2R agonists [43,49,50], tumor growth was suppressed by TMEM97/S2R knockout in a breast cancer xenograft model [51]. The gene discussed is TMEM97; the disease is breast carcinoma.